Clinical trials: Chorioretinal Vascular Disease
Chorioretinal Vascular Disease
Clinical Study to Evaluate the Handling and Safety of AVT06 PFS in Subjects With Chorioretinal Vascular Disease
This is a single-arm, open label, multicenter clinical study to evaluate the handling and safety of AVT06 pre-filled syringe (PFS) in subjects with chorioretinal vascular disease followed by an optional extension phase of AVT06…
- Trial name
- ALVOEYE-D (NCT05986786)
- Testing
- Patients will receive 1 IVT injection of AVT06 PFS depending on their chorioretinal vascular disease schedule
- Where
- Georgia
- Volunteers
- 35 people
- Sponsor
- Alvotech Swiss AG
Chorioretinal Vascular Disease
Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
The primary objective of the study is to determine if the pre-filled syringe (PFS) supports successful preparation and accurate administration of an aflibercept injection.
- Trial name
- NCT03767738
- Testing
- Intravitreal Aflibercept Injection (IAI)
- Where
- 2 sites in United States
- Volunteers
- 65 people
- Sponsor
- Regeneron Pharmaceuticals
Chorioretinal Vascular Disease
A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD)
The primary objective of this study is to is to assess the ability of retina specialists to successfully administer, via an intravitreal (IVT) injection, a 2 mg dose of ABP 938, using the ABP 938 aflibercept prefilled syringe…
- Trial name
- NCT05704725
- Testing
- ABP 938, Aflibercept
- Where
- 4 sites in United States
- Volunteers
- 49 people
- Sponsor
- Amgen